Glass House BrandsGLASF -2.28%44 Gross Margin % is 33.99% as of Mar. 2026, which is 16% below its 10-year median of 40.56. GuruFocus rates GLASF with a GF Score™ of 44/100 and a GF Value™ of $6.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 938 Drug Manufacturers companies, Glass House Brands ranks worse than 65.46% on this metric.
The historical rank and industry rank for Glass House Brands's Gross Margin % or its related term are showing as below:
GLASF'
s Gross Margin % Range Over the Past 10 Years
Min: 24.4 Med: 40.56 Max: 50.34
Current: 39.83
During the past 6 years, the highestGross Margin % of Glass House Brands was 50.34%. The lowest was 24.40%. And the median was 40.56%.
GLASF's Gross Margin % is ranked worse than 65.46% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs GLASF: 39.83
Glass House Brands had a gross margin of 33.99% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Glass House Brands was 9.40% per year.
Glass House Brands (OTCPK:GLASF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Glass House Brands had a gross margin of 33.99% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Glass House Brands Gross Margin % Related Terms
Glass House Brands Gross Margin % Historical Data
* Premium members only.
The historical data trend for Glass House Brands's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Glass House Brands's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Glass House Brands (GLASF) has a Gross Margin % of 33.99% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Glass House Brands and its competitors. This is 16% below median its historical median of 40.56. Over the past decade, Glass House Brands' Gross Margin % has ranged from 24.40 to 50.34. According to the industry distribution chart, Glass House Brands ranks #614 out of 938 companies in the Drug Manufacturers industry, placing it in the top 65.5%.
Is Glass House Brands' Gross Margin % too high?
Glass House Brands' current Gross Margin % of 33.99% is 16% below median its 10-year median of 40.56. Over the past 10 years, this metric has ranged from a low of 24.40 to a high of 50.34. The Drug Manufacturers industry median Gross Margin % is 48.44. Glass House Brands' value of 33.99% is 29.8% below this industry median. Based on the distribution chart, Glass House Brands ranks #614 out of 938 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #614 out of 938 companies for Gross Margin %. This places Glass House Brands in the lower half of its industry. The industry median Gross Margin % is 48.44. Glass House Brands' value of 33.99% is 29.8% below this benchmark. Historically, Glass House Brands' own Gross Margin % has ranged from 24.40 to 50.34 over the past decade. While the company's 10-year median is 40.56 vs. the industry median of 48.44, Glass House Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current Gross Margin % of 33.99% is 29.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Glass House Brands and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current Gross Margin % is 33.99%, which is 16% below median its own 10-year median of 40.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLASF) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.15, compared to a current price of $12.45 — trading 102.4% above its estimated fair value. The current Gross Margin % is 33.99%, which is 16% below median its 10-year median of 40.56 and 29.8% below the Drug Manufacturers industry median of 48.44. Glass House Brands' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Glass House Brands (GLASF), the current Gross Margin % is 33.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLASF) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $12.45 is trading 102.4% above its estimated GF Value™ of $6.15.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLASF:
Gross Margin %: 33.99% (16% below median its 10-year median of 40.56)
GF Value™: $6.15 vs. price of $12.45 (102.4% above fair value)
Industry Position: 29.8% below the Drug Manufacturers median (#614 of 938)
No single metric tells the full story. See the GLASF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score
Get the complete analysis for GLASF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLASF has been successfully added to your 
